Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses
Spencer, Ryan J., Amerena, John V.Volume:
15
Language:
english
Journal:
American Journal of Cardiovascular Drugs
DOI:
10.1007/s40256-015-0127-2
Date:
December, 2015
File:
PDF, 436 KB
english, 2015